1. Wu, Yinteng, Hu, Haifeng, Wang, Tao, Zhao, Shijian, Wei, Ruqiong. 2024. Characterizing mitochondrial features in osteoarthritis through integrative multi-omics and machine learning analysis. In Frontiers in immunology, 15, 1414301. doi:10.3389/fimmu.2024.1414301. https://pubmed.ncbi.nlm.nih.gov/39026663/
2. Dang, Anh-Thu, Turner, Adam W, Lau, Paulina, Soubeyrand, Sébastien, McPherson, Ruth. 2022. A novel anti-inflammatory role links the CARS2 locus to protection from coronary artery disease. In Atherosclerosis, 348, 8-15. doi:10.1016/j.atherosclerosis.2022.03.024. https://pubmed.ncbi.nlm.nih.gov/35381443/
3. Samanta, Debopam, Gokden, Murat, Willis, Erin. 2018. Clinicopathologic Findings of CARS2 Mutation. In Pediatric neurology, 87, 65-69. doi:10.1016/j.pediatrneurol.2018.06.009. https://pubmed.ncbi.nlm.nih.gov/30139652/
4. Xu, Manting, Duan, Xin, Ren, Xiaotun, Chen, Shuhua, Fang, Fang. 2021. Generation of an iPSC line from a patient with early-onset epileptic encephalopathy carrying CARS2 (p.G476R) mutation. In Stem cell research, 59, 102633. doi:10.1016/j.scr.2021.102633. https://pubmed.ncbi.nlm.nih.gov/34953328/
5. Hallmann, Kerstin, Zsurka, Gábor, Moskau-Hartmann, Susanna, Sander, Thomas, Kunz, Wolfram S. 2014. A homozygous splice-site mutation in CARS2 is associated with progressive myoclonic epilepsy. In Neurology, 83, 2183-7. doi:10.1212/WNL.0000000000001055. https://pubmed.ncbi.nlm.nih.gov/25361775/